"The whole point of the day today is to celebrate the science that we do, to share it with each other and maybe find a new collaborator or a new technique. Let's make sure to take full advantage of this day,"
"In vivo CAR T engineering may simplify immunotherapy at much lower costs,"
"Targeted LNPs delivering mRNA may be a new and flexible therapeutic platform."
Feinberg hosted its 19th annual Lewis Landsberg Research Day with students, staff, trainees and faculty presenting more than 470 research posters and abstracts across campus. Awards recognized mentorship and translational science excellence, including a Mentor of the Year award and a Tripartite Legacy Faculty Prize. A keynote outlined the potential and cost-effectiveness of mRNA and CAR T-cell approaches to treat cardiac fibrosis, noting in vivo CAR T engineering and targeted lipid nanoparticle mRNA delivery as promising, lower-cost therapeutic strategies. The event encouraged scientific sharing, collaboration and technique exchange among attendees.
Read at News Center
Unable to calculate read time
Collection
[
|
...
]